A Clinical Study Of Miasmatic Predominance In Management Of Perimenopausal Women Of Age 40-55 Years- Case Series.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To investigate predominant miasm in perimenopausal women age 40-55 years.
研究概览
简要总结
Title
A Clinical Study of Miasmatic Predominance in the Management of Perimenopausal Women (40–55 years): A Case Series
Background
Perimenopause (40–55 years) is marked by hormonal fluctuations causing somatic, psychological, and urogenital symptoms.
Conventional management is mainly symptomatic and may have adverse effects.
Homeopathy emphasizes individualization and miasmatic understanding for holistic care.
Research Gap
Limited studies on miasmatic predominance in perimenopausal women.
Insufficient evidence correlating miasms with perimenopausal symptomatology.
Need for systematic evaluation of miasmatic analysis in homeopathic management.
Research Question
Is there a significant association between miasmatic predominance and perimenopausal symptoms?
Hypothesis
There is a significant association between dominant miasm and perimenopausal symptoms.
Rationale
Perimenopause is clinically diagnosed without laboratory confirmation.
Hormonal and non-hormonal therapies have limitations and side effects.
Miasmatic approach may improve individualized and long-term outcomes in homeopathic practice.
Objectives
Primary
To identify the predominant miasm in perimenopausal women aged 40–55 years.
Secondary
To assess the effectiveness of individualized homeopathic treatment.
To identify commonly prescribed homeopathic medicines in perimenopausal cases.
Study Design & Methods
Design: Prospective case series
Sample size: 30 cases
Setting: OPD
Duration: 18 months
Sampling: Convenience sampling
Inclusion Criteria
Females aged 40–55 years
LMP < 1 year
Presence of symptoms as per MRS (>11)
Exclusion Criteria
Age <40 or >55 years
LMP >1 year
Pregnancy
Assessment Tools
Menopausal Rating Scale (MRS)
Case Record Format
Kent’s Repertory (Radar Opus)
R.P. Patel’s Chronic Miasms
MONARCH score for outcome assessment
Outcome Measures
Change in MRS score pre- and post-treatment
Identification of dominant miasm
Clinical improvement with individualized remedies
Ethical Considerations
Informed consent obtained
Confidentiality maintained
Expected Outcome
Identification of predominant miasm in perimenopausal women
Evidence supporting the role of individualized homeopathic treatment
Better understanding of miasmatic influence in perimenopause
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Females in age group 40 to 55 years 2.Females with any of the somatic, psychological and urogenital symptoms stated in MRS above
- •3.LMP less than 1 year.
- •4.Not attained menopause.
排除标准
- •1.Females below 40 ages 2.Females above 55 ages 3.LMP more than 1 year.
- •4.Pregnant women.
结局指标
主要结局
To investigate predominant miasm in perimenopausal women age 40-55 years.
时间窗: Baseline
次要结局
- To study the effectiveness of Individualized homoeopathic Medicine in Perimenopausal complaints in age group 40 to 55 years.(Baseline)
- To identify the commonly prescribed homoeopathic medicine in Perimenopausal complaints in age group 40 to 55 years.(After 6 months)
研究者
Dr Aqsa Shaikh
Motiwala (National) Homoeopathic Medical College and Hospital, Nashik.